ProCE Banner Activity

BCL-2 Targeted Therapy in B-Cell Lymphomas: A Summary Resource

PDF
Download this online resource developed to serve as a helpful guide for healthcare professionals on BCL-2 targeted therapies in B-cell lymphoma.

Released: December 10, 2021

Expiration: December 09, 2022

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Atara Biotherapeutics

Bayer Healthcare Pharma

BeiGene, Ltd.

Epizyme

Genentech, a member of the Roche Group

Genmab US, Inc.

Incyte Corporation

Karyopharm Therapeutics

Pharmacyclics LLC an AbbVie Company and Janssen Biotech Inc